| Literature DB >> 26580281 |
Juexin Fan1, Bin Zhang2, Lili Li3, Chaowu Xiao4, Oso Abimbola Oladele5, Guoli Jiang3, Hao Ding1, Shengping Wang3, Yueteng Xing1, Dingfu Xiao2, Yulong Yin3.
Abstract
This study was to investigate the effect of soyabean isoflavones (SIF) on onset of puberty, serum hormone concentration, and gene expression in hypothalamus, pituitary and ovary of female Bama miniature pigs. Fifty five, 35-days old pigs were randomly assigned into 5 treatment groups consisting of 11 pigs per treatment. Results showed that dietary supplementation of varying dosage (0, 250, 500, and 1,250 mg/kg) of SIF induced puberty delay of the pigs with the age of puberty of pigs fed basal diet supplemented with 1,250 mg/kg SIF was significantly higher (p<0.05) compared to control. Supplementation of SIF or estradiol valerate (EV) reduced (p<0.05) serum gonadotrophin releasing hormone and luteinizing hormone concentration, but increased follicle-stimulating hormone concentration in pigs at 4 months of age. The expression of KiSS-1 metastasis-suppressor (KISS1), steroidogenic acute regulatory protein (StAR) and 3-beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase (3β-HSD) was reduced (p<0.01) in SIF-supplemented groups. Expression of gonadotropin-releasing hormone receptor in the pituitary of miniature pigs was reduced (p<0.05) compared to the control when exposed to 250, 1,250 mg/kg SIF and EV. Pigs on 250 mg/kg SIF and EV also showed reduced (p<0.05) expression of cytochrome P450 19A1 compared to the control. Our results indicated that dietary supplementation of SIF induced puberty delay, which may be due to down-regulation of key genes that play vital roles in the synthesis of steroid hormones.Entities:
Keywords: Bama Miniature Pigs; Puberty; Puberty Delay; Soybean Isoflavones
Year: 2015 PMID: 26580281 PMCID: PMC4647097 DOI: 10.5713/ajas.15.0185
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Composition of experimental diets fed to pigs in stage 1 (d 35 to d 95) and stage 2 (d 96 to farrow)
| Items | Diets | |
|---|---|---|
|
| ||
| Stage 1 | Stage 2 | |
| Ingredient (%) | ||
| Corn | 41.49 | 40 |
| Wheat bran | 20 | 24 |
| Wheat middlings | 15 | 11.85 |
| Rice bran | 10 | 12 |
| Fish meal | 6 | - |
| Rapeseed meal | 3 | 3 |
| Corn gluten meal | 2 | - |
| Rice protein powder | - | 4.73 |
| Limestone | 0.77 | 1.968 |
| Dicalcium phosphate | 0.24 | 1.072 |
| Lysine | 0.28 | 0.09 |
| Salt | 0.15 | 0.208 |
| Choline | 0.08 | 0.08 |
| Premix | 1 | 1 |
| Total | 100 | 100 |
| Calculated composition (%) | ||
| DE (kcal/kg) | 2,982 | 2,900 |
| CP | 15.5 | 14.5 |
| Lys | 0.88 | 0.6 |
| Met+Cys | 0.549 | 0.403 |
| Ca | 0.74 | 1 |
| TP | 0.79 | 0.8 |
| AP | 0.35 | 0.3 |
DE, digestible energy; CP, crude protein; TP, total phosphrous; AP, apparent phosphrous.
Diet of stage 1 supplied per kilogram of diet: Cu, 4.54 mg; Fe, 90.9 mg; Mn, 3 mg; Zn, 90.9 mg; I, 0.12 mg; Se, 0.26 mg; vitamin A, 65,000 IU; vitamin D, 18,750 IU; vitamin E, 175 IU; vitamin K3, 25 mg; vitamin B1, 25 mg; riboflavin, 55 mg; vitamin B6, 30 mg; vitamin B12, 0.19 mg; niacin, 250 mg; folic acid, 10 mg; calcium pantothenate, 125 mg; biotin, 1 mg.
Diet of stage 2 supplied per kilogram of diet: Cu, 4.2 mg; Fe, 73.5 mg; Mn, 16.8 mg; Zn, 52.5 mg; I, 0.13 mg; Se, 0.16 mg; vitamin A, 70,000 IU; vitamin D, 21,250 IU; vitamin E, 0.3 g; vitamin K3, 25 mg; vitamin B1, 25 mg; riboflavin, 55 mg; vitamin B6, 35 mg; vitamin B12, 0.25 mg; niacin, 300 mg; folic acid, 30 mg; calcium pantothenate, 125 mg; biotin, 2.25 mg.
Primer sequences and accession number used for measurements of selected genes using RT-PCR
| Genes | Accession No. | Nucleotide sequence | Product length (bp) |
|---|---|---|---|
| NM_213978.1 | F: TTTCTACCTTCTGGTCCACACTG | 102 | |
| NM_001134964.1 | F: GGACCTCATCGTGCCAGCCT | 152 | |
| DQ459346.1 | F: CGTGCCCTTTACTGCTCTACTC | 160 | |
| NM_214274.1 | F: GAGCCAATTCCGAAACTTCTAGC | 267 | |
| NM_214273.1 | F: CTTCCCACCCTGACCTTATCT | 121 | |
| NM_213875.1 | F: CCCATCTCCCAATCTGTCTCA | 162 | |
| NM_214080.1 | F: TGTTGTGGCTGCTGCTGAG | 137 | |
| NM_213755.2 | F: GACGGATGGAAGGGATAGTTG | 228 | |
| NM_001004049.1 | F: CCTTCAATCGCCACTTCG | 220 | |
| NM_214427.1 | F: GCTCGGCAACTTGGAATCT | 98 | |
| NM_214428.1 | F: AGAACTACAGCAGAAACTCCATCA | 186 | |
| NM_214429.1 | F: GAGGAGGTCCGCAATGACTT | 88 | |
| NM_214386.2 | F: ACTGGAGGCGGCAAATCT | 133 | |
| NM_214449.1 | F: CAAGGAGACCAAATAATGAAACAC | 326 |
RT-PCR, real-time polymerase chain reaction; B2M, beta-2-microglobulin; KISS1, KiSS-1 metastasis-suppressor; GPR54, G protein-coupled receptor 54; GNRH1, gonadotropin-releasing hormone 1; GNRHR, gonadotropin-releasing hormone receptor; FSHβ, follicle stimulating hormone, beta polypeptide; LHβ, luteinizing hormone-beta; StAR, steroidogenic acute regulatory protein; 3β-HSD, 3-beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase; CYP11A1, cytochrome P450, family 11, subfamily A, polypeptide 1; CYP17A1, cytochrome P450 17A1; CYP19A1, cytochrome P450 19A1; FSHR, follicle stimulating hormone receptor; LHR, luteinizing hormone/choriogonadotropin receptor.
Effects of soybean isoflavones on estrus ratio of female Bama miniature pigs
| Age (d) | Control (n = 11) | SIF 250 (n = 9) | SIF 500 (n = 10) | SIF 1250 (n = 10) | EV 0.66 (n = 11) |
|---|---|---|---|---|---|
| 150 | 5 (45)a | 1 (11) | 1 (10) | 0 | 1 (9) |
| 180 | 7 (63.6) | 3 (33.3) | 4 (40) | 0 | 3 (27.3) |
| 210 | 11 (100) | 4 (44.4) | 5 (50) | 2 (20) | 6 (54.5) |
| 240 | 11 (100) | 5 (55.6) | 7 (70) | 6 (60) | 8 (72.7) |
SIF, soyabean isoflavones; EV, estradiol valerate.
Values are expressed as ratio of the number of pigs which showed estrous reflex to total number of survived pigs per treatment (%).
Effects of soybean isoflavones on age of puberty of Bama miniature pigs
| Variable | Control | SIF-250 | SIF-500 | SIF-1250 | EV-0.66 |
|---|---|---|---|---|---|
| Gilts numbers | 11 | 5 | 7 | 6 | 8 |
| Age of puberty (d) | 169.00±8.01 | 182.60±17.96 | 182.86±13.66 | 212.00±5.90 | 188.25±11.34 |
SIF, soyabean isoflavones; EV, estradiol valerate.
Letters on the same row with different superscripts differs significantly (p<0.05).
Serum hormone concentration of the pigs following treatment of SIF and EV
| Variable | Control | SIF-250 | SIF-500 | SIF-1250 | EV-0.66 |
|---|---|---|---|---|---|
| 4 mo of age | |||||
| GnRH (pg/mL) | 18.74±3.44 | 11.84±1.14 | 10.36±2.07 | 7.06±1.86 | 7.72±1.30 |
| E2 (pg/mL) | 97.79±9.37 | 77.68±12.94 | 122.93±8.72 | 77.29±9.03 | 80.63±7.45 |
| FSH (mIU/mL) | 4.51±0.08 | 4.74±0.06 | 4.79±0.09 | 4.96±0.10 | 4.97±0.10 |
| LH (mIU/mL) | 4.44±1.09 | 1.65±0.18 | 1.94±0.35 | 1.34±0.45 | 1.04±0.19 |
| P4 (ng/mL) | 17.98±5.46 | 3.51±0.81 | 8.54±2.15 | 12.30±4.04 | 4.80±1.41 |
| 2nd d of estrus | |||||
| GnRH (pg/mL) | 50.44±4.59 | 12.77±0.36 | 16.33±4.11 | 40.73±16.46 | 12.28±2.65 |
| E2 (pg/mL) | 109.13±11.07 | 90.45±3.62 | 92.64±6.30 | 127.70±11.30 | 105.16±3.06 |
| FSH (mIU/mL) | 1.38±0.04 | 1.37±0.02 | 1.38±0.03 | 1.33±0.05 | 1.45±0.07 |
| LH (mIU/ mL) | 5.87±0.48 | 3.29±0.52 | 3.37±0.43 | 4.91±1.50 | 2.76±0.37 |
| P4 (ng/mL) | 25.40±3.12 | 7.99±1.14 | 18.55±0.83 | 31.18±4.95 | 23.36±2.20 |
| 4th day of estrus | |||||
| GnRH (pg/mL) | 44.74±14.00 | 17.36±5.24 | 10.09±3.42 | 45.17±13.98 | 12.70±2.97 |
| E2 (pg/mL) | 129.87±20.35 | 112.28±34.05 | 87.88±14.06 | 159.70±23.37 | 143.28±31.44 |
| FSH (mIU/mL) | 1.38±0.04 | 1.32±0.01 | 1.33±0.03 | 1.35±0.05 | 1.42±0.03 |
| LH (mIU/ mL) | 5.65±0.32 | 4.54±0.32 | 2.25±0.37 | 3.40±0.55 | 3.45±0.28 |
| P4 (ng/mL) | 50.21±4.51 | 39.93±6.98 | 28.76±4.05 | 37.75±5.22 | 33.37±1.98 |
SIF, soyabean isoflavones; EV, estradiol valerate; GnRH, gonadotrophin releasing hormone; E2, estrogen; FSH, follicle-stimulating hormone; LH, luteinizing hormone; P4, progesterone.
Letters on the same row with different superscripts differs significantly (p<0.05).
Figure 1Effects of soyabean isoflavones (SIF) on the expression of genes in the hypothalamus of the mini-pigs. Pigs were exposed to varing dosages (0, 250, 500, and 1,250 mg/kg) of SIF and estradiol valerate (EV; 0.66 mg/kg). The hypothalamus samples (n = 6 per treatment) from each pig was separated and frozen in liquid N, and then stored at −80°C. Gene expression were analyzed by RT-PCR. Data were presented as mean±standard error of the mean.
Figure 2Effects of soyabean isoflavones (SIF) on the expression of genes in the pituitary of the mini-pigs. Pigs were exposed to varing dosages (0, 250, 500, and 1,250 mg/kg) of SIF and estradiol valerate (EV; 0.66 mg/kg). The pituitary gland samples (n = 6 per treatment) from each pig was separated and frozen in liquid N, and then stored at −80°C. Gene expression were analyzed by RT-PCR. Data were presented as mean±standard error of the mean.
Figure 3Effects of soyabean isoflavones (SIF) on the expression of steroid hormone genes in the ovary of the mini-pigs. Pigs were exposed to varing dosages (0, 250, 500, and 1,250 mg/kg) of SIF and estradiol valerate (EV; 0.66 mg/kg). The pigs were slaughtered and ovary samples (n = 6 per treatment) were separated and frozen in liquid N, and then stored at −80°C. Steroid hormone gene expression were analyzed by RT-PCR. Data were presented as mean±standard error of the mean. RT-PCR, real-time polymerase chain reaction.
Figure 4Effects of soyabean isoflavones (SIF) on the protein expression of steroid hormones in the ovary of the mini-pigs. Pigs were exposed to varing dosages (0, 250, 500, and 1,250 mg/kg) of SIF and estradiol valerate (EV; 0.66 mg/kg). The pigs were slaughtered and ovary samples (n = 3 per treatment) were separated and frozen in liquid N, and then stored at −80°C. Steroid hormone protein expression were analyzed by Western blot. Data were presented as mean±standard error of the mean.